Leuprolide, also known as leuprorelin, is a synthetic gonadotropin-releasing hormone (GnRH) agonist medication that mimics the natural hormone produced in the brain to regulate reproductive functions. It binds to pituitary GnRH receptors, initially stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which temporarily boosts sex hormone levels like testosterone and estrogen before downregulating them through continuous receptor activation. This mechanism suppresses ovarian and testicular steroidogenesis, effectively treating hormone-dependent conditions. Primary uses include palliative management of advanced prostate cancer by reducing testosterone, alleviation of endometriosis symptoms by lowering estrogen, treatment of uterine fibroids to shrink tumors and control bleeding, and control of central precocious puberty in children to delay early sexual development. Off-label applications encompass breast cancer therapy and transgender hormone management. Available as injections under brand names like Lupron and Eligard, it is prescribed for specific durations tailored to the condition.